UK Remote Patient Monitoring (RPM) Market (2026-2031)
The UK Remote Patient Monitoring (RPM) Market was valued at $1427 Million in 2026 and projected to reach to $2490.1 Million by 2031, representing a compound annual growth rate of 11.8%. The UK Remote Patient Monitoring market is positioned as a cornerstone of the nation's digital health transformation strategy.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Remote Patient Monitoring (RPM) Market Trends and Insights
- Valued at USD 1,427.0 million in 2026, the UK market is projected to expand to USD 2,490.1 million by 2031, reflecting an 11.8% compound annual growth rate.
- This growth trajectory underscores the UK's commitment to leveraging connected health technologies to enhance patient outcomes and reduce healthcare burden across the National Health Service and private providers. The UK's RPM adoption is driven by aging demographics, rising chronic disease prevalence, and government initiatives promoting remote care delivery.
- The UK market benefits from strong digital infrastructure, regulatory clarity through MHRA oversight, and increasing NHS integration of remote monitoring solutions.
- Between 2026 and 2031, the UK is expected to see accelerated deployment across cardiovascular, respiratory, and diabetes management segments, supported by reimbursement frameworks and clinical evidence accumulation. The UK's competitive environment features both established medical device manufacturers and innovative digital health startups.
- Market maturation in the UK reflects broader European trends while maintaining distinct regulatory and procurement pathways.
- The forecast period positions the UK as a key growth market within Europe's RPM landscape..
Key Market Statistics
- CAGR (2026-2031) 11.8% CAGR
- Market Size, 2026 ~USD 1427 Million
- Forecast, 2031 ~USD 2490.1 Million
- Country UK
UK Remote Patient Monitoring (RPM) Market Overview
Market Valuation Growth :
The UK RPM market is valued at USD 1,427.0 million in 2026 and is projected to reach USD 2,490.1 million by 2031, demonstrating robust expansion driven by NHS digital initiatives and chronic disease management priorities.
Consistent CAGR Performance :
The UK market is growing at an 11.8% CAGR from 2026-2031, slightly below the global average of 12.8%, reflecting steady adoption of remote monitoring technologies across UK healthcare systems.
NHS Digital Transformation :
UK's National Health Service is accelerating digital health adoption, with RPM technologies becoming integral to reducing hospital readmissions, managing long-term conditions, and improving patient outcomes across primary and secondary care.
Aging Population Demand :
The UK's aging demographic and rising prevalence of chronic conditions such as diabetes, hypertension, and COPD are driving demand for continuous remote monitoring solutions to support community-based care models.
UK Remote Patient Monitoring (RPM) Market Dynamics
- With NHS funding increasingly directed toward connected health technologies and integrated care systems, RPM adoption is accelerating across primary care networks, secondary care facilities, and community health providers.
- The market's 11.8% CAGR reflects growing confidence in RPM's clinical efficacy and cost-effectiveness in managing chronic diseases and reducing healthcare burden. Looking ahead to 2031, the UK market will be shaped by regulatory frameworks supporting interoperability, expanded reimbursement models for remote monitoring services, and integration with electronic health records.
- Investment in digital infrastructure, coupled with patient acceptance of wearable and connected devices, will drive market expansion.
- Key growth areas include cardiovascular monitoring, respiratory disease management, and post-acute care pathways, positioning the UK as a mature RPM market within Europe..
Related Ecosystem
Cardiovascular Devices
Diagnostic Imaging
Healthcare It
Key Takeaways
- The UK RPM market will grow from USD 1,427.0M (2026) to USD 2,490.1M (2031) at an 11.8% CAGR, driven by NHS digitalization and chronic disease management priorities.
- The UK's aging population and prevalence of cardiovascular and respiratory conditions create sustained demand for remote monitoring solutions through 2031.
- The UK regulatory environment and MHRA approval pathways provide competitive advantages for established and emerging RPM vendors targeting the market.
- The UK market integration with NHS procurement and reimbursement frameworks will accelerate RPM adoption across primary, secondary, and community care settings by 2031.
Remote Patient Monitoring (RPM) Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SYNCHRONOUS (Transmission Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 12.8% from 2026 to 2031 |
| Largest Segment | HEALTHCARE PROVIDERS (End User) |
| Market Size Base Year (Billions) | ~USD 36.32 (2026) |
| Revenue Forecast (Billions) | ~USD 66.33 (2031) |
| Segments Covered | Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type |
UK Remote Patient Monitoring (RPM) Market Report Segmentation
8 segment dimensions are covered across the global market.
By Component
- Devices
- Services
- Software
By Function
- Blood Glucose Monitoring
- Cardiac Monitoring
- Fetal & Neonatal Monitoring
- Multiparameter Monitoring
- Neurological Monitoring
- Other Monitoring Devices
- Pulse Oximeters
- Respiratory Monitoring
- Thermometers
- Weight Monitoring
By Type
- Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
- Handheld & Portable
- Handheld & Portable Devices
- Home Healthcare
- Hospitals
- Implantable
- Implantable Devices
- Long-Term Care & Assisted Living Facilities
- Other Healthcare Providers
- Others (Stationary Devices And Others)
- Others (Stationary Devices, And Others)
- Wearable
- Wearable Devices
By Deployment Model
- Cloud-Based Model
- On-Premise Model
By Transmission Type
- Asynchronous
- Synchronous
By Indication
- Cardiology
- Diabetes
- Mental Health
- Neurology
- Oncology
- Other Indications
- Respiratory Disorders
- Sleep Disorders
- Wellness Improvement
By End User
- Healthcare Payers
- Healthcare Providers
- Medtech Companies
- Other End Users
- Patients
- Pharmaceutical & Biotechnology Companies
By Deployment Type
- Cloud-Based
- On-Premises
UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HEALTHCARE PAYERS | 276.9 | 315.4 | 357.3 | 402.9 | 452.8 | 507.1 | 565.9 | 629.7 | 12 |
| HEALTHCARE PROVIDERS | 460.7 | 523.2 | 590.9 | 664.4 | 744.4 | 831.1 | 924.7 | 1026 | 11.7 |
| MEDTECH COMPANIES | 51.5 | 58.2 | 65.5 | 73.2 | 81.6 | 90.7 | 100.4 | 110.8 | 11.1 |
| OTHER END USERS | 34.3 | 38.8 | 43.5 | 48.6 | 54.1 | 60 | 66.2 | 72.9 | 10.8 |
| PATIENTS | 188.5 | 215.3 | 244.7 | 276.8 | 312 | 350.4 | 392.1 | 437.7 | 12.3 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 98.4 | 111.3 | 125.2 | 140.2 | 156.4 | 174 | 192.8 | 213 | 11.2 |
| TOTAL | 1110.3 | 1262.3 | 1427 | 1606.2 | 1801.4 | 2013.2 | 2242 | 2490.1 | 11.8 |
Target Audience
- NHS Trust Executives : Hospital and primary care leaders need UK market data to justify RPM investments, understand adoption benchmarks, and align digital health strategies with national NHS priorities and funding availability.
- Healthcare Technology Vendors : RPM solution providers require UK-specific market intelligence to assess market size, identify growth segments, understand competitive dynamics, and develop localized go-to-market strategies for NHS procurement.
- Private Healthcare Operators : Private hospital groups and independent care providers need UK market insights to evaluate RPM adoption opportunities, understand patient demand, and position services competitively against NHS offerings.
- Medical Device Manufacturers : Wearable and connected device manufacturers need UK market forecasts to guide product development, regulatory strategy, and distribution partnerships aligned with NHS digital health requirements.
- Healthcare Investors & Consultants : Investment firms and management consultants require detailed UK RPM market analysis to identify investment opportunities, assess portfolio company positioning, and support strategic advisory engagements with healthcare clients.
Key Companies in the UK Remote Patient Monitoring (RPM) Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring), |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| ORACLE | United States | Public Company | Cloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain), |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services), |
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.
MEDTRONIC
Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.
GE HEALTHCARE
GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.
ABBOTT
Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.
ORACLE
Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.
NIHON KOHDEN CORPORATION
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.
SIEMENS HEALTHINEERS AG
Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.
BAXTER
Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.
Reasons to Buy this Report
- UK-Specific Market Sizing : Access precise valuation data for the UK RPM market with detailed forecasts through 2031, enabling accurate budget allocation and investment planning tailored to the British healthcare landscape.
- NHS Integration Insights : Understand how RPM technologies are being integrated into NHS systems, Integrated Care Boards, and primary care networks, with actionable intelligence on procurement trends and adoption barriers specific to UK healthcare structures.
- Regulatory & Reimbursement Landscape : Gain clarity on UK-specific regulatory requirements, NICE guidance, and NHS reimbursement pathways for remote monitoring services, critical for market entry and commercial strategy development.
- Competitive Positioning : Identify key UK market players, emerging competitors, and partnership opportunities within the British healthcare ecosystem to inform competitive strategy and market differentiation.
- Growth Opportunity Assessment : Evaluate high-potential segments within the UK market, including aging population demographics, chronic disease prevalence, and underserved regions, to prioritize expansion and resource allocation.
Frequently asked questions
What is the current size of the UK Remote Patient Monitoring market?
The UK RPM market is valued at USD 1,427.0 million in 2026 and is projected to reach USD 2,490.1 million by 2031.
What is the expected growth rate of the UK RPM market?
The UK RPM market is expected to grow at a compound annual growth rate (CAGR) of 11.8% from 2026 to 2031.
Which factors are driving RPM adoption in the UK?
Key drivers include an aging population, rising chronic disease prevalence, NHS digitalization initiatives, strong digital infrastructure, and government support for remote care delivery models.
What clinical conditions are most targeted by RPM solutions in the UK?
The UK market shows strong adoption in cardiovascular disease, respiratory conditions, and diabetes management, supported by clinical evidence and NHS integration pathways.
How does the UK regulatory environment impact RPM market growth?
The UK's MHRA oversight, clear regulatory pathways, and NHS procurement frameworks create a favorable environment for RPM vendor entry and market expansion through 2031.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the remote patient monitoring market.
Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.
Market Definition
The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.
Key Stakeholders
- RPM Equipment and devices Manufacturers
- Suppliers and Distributors of RPM Equipment
- RPM software provider
- Healthcare IT Service Providers
- Healthcare Insurance Companies/Payers
- Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
- Venture Capitalists
- Government Bodies/Regulatory Bodies
- Corporate Entities
- Accountable Care Organizations
- RPM Resource Centers
- Research and Consulting Firms
- Medical Research Institutes
- Clinical Departments
Report Objectives
- To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
- To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries
Get the Full Remote Patient Monitoring (RPM) Market Report
Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.
- Rest Of Europe Remote Patient Monitoring (RPM) Market
- Rest Of Asia Pacific Remote Patient Monitoring (RPM) Market
- Canada Remote Patient Monitoring (RPM) Market
- US Remote Patient Monitoring (RPM) Market
- Germany Remote Patient Monitoring (RPM) Market
- France Remote Patient Monitoring (RPM) Market
- Italy Remote Patient Monitoring (RPM) Market
- Spain Remote Patient Monitoring (RPM) Market
- China Remote Patient Monitoring (RPM) Market
- Japan Remote Patient Monitoring (RPM) Market
- India Remote Patient Monitoring (RPM) Market
- Australia Remote Patient Monitoring (RPM) Market
- South Korea Remote Patient Monitoring (RPM) Market
- Brazil Remote Patient Monitoring (RPM) Market
- Mexico Remote Patient Monitoring (RPM) Market
- Saudi Arabia Remote Patient Monitoring (RPM) Market
- UAE Remote Patient Monitoring (RPM) Market
- South Africa Remote Patient Monitoring (RPM) Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report